Stay updated on Denosumab + PD-1 in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Denosumab + PD-1 in Melanoma Clinical Trial page.

Latest updates to the Denosumab + PD-1 in Melanoma Clinical Trial page
- Check3 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4; no changes to study details, eligibility criteria, endpoints, or results are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page now shows a consolidated Locations section listing New Hampshire and North Carolina as study sites, replacing the previous separate location entries. The revision is updated to v3.3.3.SummaryDifference0.3%

- Check54 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedThe government funding status notice has been removed from the page. The remaining content appears unchanged.SummaryDifference0.3%

- Check75 days agoChange DetectedPage content remained largely unchanged with no new sections or removed content; the latest updates appear to be routine and do not alter the core information about the NCT03620019 study.SummaryDifference0.4%

- Check104 days agoChange DetectedCore page now conveys updated operating status and a version upgrade to v3.2.0, replacing the prior v3.1.0; reflects current status and new release.SummaryDifference2%

Stay in the know with updates to Denosumab + PD-1 in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Denosumab + PD-1 in Melanoma Clinical Trial page.